Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04091867
Title sEphB4-HSA With Cetuximab and RT in Patients With High Risk, LAHNSCC and Heavy Smoking Histories
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab + sEphB4-HSA

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.